Article in Microbiology resource announcements, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Simon D WeaverDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0003-4354-0309
Daniel D HuDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Bradley S JonesDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Patricia A ChampionDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0002-6733-596X
Matthew M ChampionDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0001-5927-5277
Funding
Role of N-alpha acetylation in mycobacterial secretion and virulenceR01AI106872 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2013 to 2024
$4.2M
Chemistry-Biochemistry-Biology Training Program at Notre DameT32GM075762 · NIGMS · UNIVERSITY OF NOTRE DAME · PI CHANG, MAYLAND F, MOBASHERY, SHAHRIAR · 2007 to 2021
$3.7M
Systematic Discovery and Analysis of Small Proteins and Small ORFs in MycobacteriaR01GM139277 · NIGMS · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, GRAY, TODD · 2020 to 2023
$2.2M
Dissecting and connecting the SigM stimulus and ESX-4 secretory response in mycobacteriaR01GM144372 · NIGMS · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, GRAY, TODD · 2022 to 2023
$771k
Investigating the molecular requirements for ESX-1-lytic activity in pathogenic mycobacteriaR21AI156229 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2021 to 2022
$430k
Mechanisms of ESX-1-dependent Gene Expression in Pathogenic MycobacteriaR21AI149235 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2020 to 2021
$425k
Development of an electrophoretic platform for bacteriophage discoveryR21AI178332 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, MATTHEW M · 2024 to 2025
$425k
The requirement for PDIM in mycobacterial protein secretionR03AI149147 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2020 to 2021
$156k
National Institute of Allergy and Infectious Diseases AI156229, AI106872, AI149147, AI149235National Institute of Allergy and Infectious Diseases AI178332NIAID NIH HHS R01 AI106872NIAID NIH HHS R03 AI149147NIAID NIH HHS R21 AI149235NIAID NIH HHS R21 AI156229NIAID NIH HHS R21 AI178332NIGMS NIH HHS GM144372, GM139277NIGMS NIH HHS R01 GM139277NIGMS NIH HHS R01 GM144372NIGMS NIH HHS T32 GM075762NIGMS NIH HHS T32GM075762
6 · The paper itself
Abstract
We investigated the chemical and functional consequences of a
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.